Yi Lun

851 total citations
19 papers, 610 citations indexed

About

Yi Lun is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yi Lun has authored 19 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Yi Lun's work include Lysosomal Storage Disorders Research (11 papers), Glycosylation and Glycoproteins Research (4 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). Yi Lun is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Glycosylation and Glycoproteins Research (4 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). Yi Lun collaborates with scholars based in United States, China and South Africa. Yi Lun's co-authors include Richie Khanna, Kenneth J. Valenzano, David J. Lockhart, Rebecca Soska, Jessie Feng, Lee Pellegrino, Michelle Frascella, Elfrida R. Benjamin, Adriane Schilling and Brandon A. Wustman and has published in prestigious journals such as Journal of Neuroscience, Nano Letters and PLoS ONE.

In The Last Decade

Yi Lun

17 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Lun United States 9 470 212 192 183 176 19 610
Rebecca Soska United States 7 429 0.9× 160 0.8× 201 1.0× 171 0.9× 166 0.9× 11 506
Lihsueh Lee United States 8 261 0.6× 331 1.6× 122 0.6× 122 0.7× 81 0.5× 10 623
Caterina Porto Italy 9 496 1.1× 202 1.0× 224 1.2× 168 0.9× 213 1.2× 11 620
Allan Powe United States 7 520 1.1× 332 1.6× 283 1.5× 272 1.5× 164 0.9× 9 725
H. Christomanou Germany 13 420 0.9× 297 1.4× 120 0.6× 184 1.0× 74 0.4× 25 557
Eric Crombez United States 17 448 1.0× 457 2.2× 117 0.6× 140 0.8× 111 0.6× 30 856
Elfrida R. Benjamin United States 13 800 1.7× 355 1.7× 388 2.0× 325 1.8× 334 1.9× 22 961
Galina Baydakova Russia 12 259 0.6× 163 0.8× 51 0.3× 102 0.6× 75 0.4× 46 435
Sunqu Zhang Canada 10 350 0.7× 255 1.2× 41 0.2× 224 1.2× 97 0.6× 11 529
Ladislav Kuchař Czechia 11 182 0.4× 192 0.9× 49 0.3× 87 0.5× 72 0.4× 25 376

Countries citing papers authored by Yi Lun

Since Specialization
Citations

This map shows the geographic impact of Yi Lun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lun more than expected).

Fields of papers citing papers by Yi Lun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Lun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lun. The network helps show where Yi Lun may publish in the future.

Co-authorship network of co-authors of Yi Lun

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Lun. A scholar is included among the top collaborators of Yi Lun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Lun. Yi Lun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lun, Yi, Jiani Li, Juncai Ma, et al.. (2024). Engineering a Self-Assembled Protein Cage for Targeted Dual Functionalization. Nano Letters. 24(30). 9237–9244. 5 indexed citations
2.
Zhang, Shaowei, et al.. (2024). Genome-Wide Characterization of the Aldehyde Dehydrogenase Gene Superfamily in Maize and Its Potential Role in Anther Development. ACS Agricultural Science & Technology. 4(1). 118–128. 2 indexed citations
4.
Kang, Wei, et al.. (2021). Nanobody Conjugates for Targeted Cancer Therapy and Imaging. Technology in Cancer Research & Treatment. 20. 2203752005–2203752005. 30 indexed citations
5.
Khanna, Richie, Virginia D. Schmith, Yi Lun, et al.. (2021). Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice. Clinical Pharmacology in Drug Development. 10(9). 1075–1088. 7 indexed citations
6.
Xu, Su, Yi Lun, Michelle Frascella, et al.. (2019). Improved efficacy of a next-generation ERT in murine Pompe disease. JCI Insight. 4(5). 59 indexed citations
9.
Khanna, Richie, Su Xu, Yi Lun, et al.. (2013). Exploring the use of a co-formulated pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase for Pompe disease. Molecular Genetics and Metabolism. 108(2). S53–S53. 1 indexed citations
10.
Khanna, Richie, John J. Flanagan, Jessie Feng, et al.. (2012). The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease. PLoS ONE. 7(7). e40776–e40776. 66 indexed citations
11.
Benjamin, Elfrida R., Richie Khanna, Adriane Schilling, et al.. (2012). Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice. Molecular Therapy. 20(4). 717–726. 71 indexed citations
12.
Lun, Yi, Anthony C. Stevens, Hadis Williams, et al.. (2012). Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid-β Peptide. Journal of Neuroscience. 32(15). 5223–5236. 75 indexed citations
13.
Khanna, Richie, Lee Pellegrino, Rebecca Soska, et al.. (2012). Exploring the Use of Pharmacological Chaperone AT3375 Alone and in Combination with Recombinant human ß-Glucosidase for Gaucher Disease. Molecular Genetics and Metabolism. 105(2). S40–S40. 3 indexed citations
14.
Khanna, Richie, Elfrida R. Benjamin, Lee Pellegrino, et al.. (2010). The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase. FEBS Journal. 277(7). 1618–1638. 127 indexed citations
15.
Khanna, Richie, Rebecca Soska, Yi Lun, et al.. (2009). The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease. Molecular Therapy. 18(1). 23–33. 107 indexed citations
16.
Khanna, Rajiv, Yi Lun, Allan Powe, et al.. (2009). G.P.8.05 The pharmacological chaperone AT2220 increases mutant acid alpha-glucosidase levels and reduces tissue glycogen in a mouse model of Pompe disease. Neuromuscular Disorders. 19(8-9). 592–592. 1 indexed citations
17.
Khanna, Richie, Elfrida R. Benjamin, Rebecca Soska, et al.. (2008). 50. The pharmacological chaperone AT1001 and treatment of Fabry disease. Molecular Genetics and Metabolism. 93(2). 26–26. 1 indexed citations
18.
Lun, Yi. (2006). AMWFA Method Applied to Comparative Analysis of Two-dimensional Data with Overlapped Peaks. Gaodeng xuexiao huaxue xuebao. 5 indexed citations
19.
Lun, Yi. (2006). Comparative Analysis of Volatile Constituents in Chenpi of Different Original Plants by GC-MS and AMWFA. Gaodeng xuexiao huaxue xuebao. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026